PATENT CLAIM ANALYSIS

Application Number: 16008991
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["536", "024500"]

Abstract:
The present invention relates generally to methods and compositions for gene therapy and immunotherapy that activate gamma delta T-cells, and in particular, can be used in the treatment of various cancers and infectious diseases.

Claim (Index 4):
The method of  claim 3 , wherein the packaging cell produces the immunotherapy-based composition following transfection with the immunotherapy-based viral delivery system.

Metadata:
- Claim Count in Document: 40.0
- Percentile: 94.0
- Lexical Diversity: 1.15625
- Patent Class: 536.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15706481', '15652080', '15849062', '15904131', '15668223']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7619396482167173
- 35 USC 102 Novelty (BERT): 0.6096573109988066
- Combined Prediction Score: 0.7467114144949263
- Mean Citation Score: 655.757314
- Max Citation Score: 760.28394
- Similarity Product: 464.0692213546014

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test